|
|
||||||||
B and Mitogen-Activated Protein Kinase Signaling Pathways in IL-1ß-Mediated Induction of
-PDGF Receptor Expression in Rat Pulmonary Myofibroblasts
Airway Inflammation Section, Laboratory of Pulmonary Pathobiology, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709
Induction of the
-platelet-derived growth factor receptor
(PDGF-R
) by IL-1ß in lung myofibroblasts enhances mitogenic and
chemotactic responses to PDGF, and this could be a mechanism of
myofibroblast hyperplasia during lung fibrogenesis. Since the
regulation of many genes by IL-1ß involves activation of NF-
B and
mitogen-activated protein (MAP) kinases, we examined these signaling
pathways in the control of PDGF-R
expression by IL-1ß in cultured
rat lung myofibroblasts. Treatment of cells with pyrrolidine
dithiocarbamate (PDTC), an antioxidant that inhibits NF-
B
activation, completely blocked PDGF-R
up-regulation by IL-1ß as
assayed by [125I]PDGF-AA binding and PDGF-R
mRNA
expression, suggesting a role for NF-
B. However, while IL-1ß and
TNF-
both induced nuclear binding of the Rel proteins p50 and p65 to
an NF-
B consensus oligonucleotide in gel shift assays and caused
transient degradation of inhibitor of NF-
B-
(I
B-
) in the
cytoplasm of myofibroblasts, only IL-1ß up-regulated PDGF-R
. These
results suggest that NF-
B activation alone is not sufficient for
up-regulation of PDGF-R
. An investigation of MAP kinase signaling
pathways revealed that IL-1ß or PDTC activated extracellular
signal-regulated kinase-2 (ERK-2) and c-jun
NH2 terminal kinase-1 (JNK-1) phosphorylation of
PHAS-1 and c-Jun substrates, respectively. Pretreatment of cells
with the MAP kinase kinase-1 (MEK1) inhibitor PD 98059 blocked
IL-1ß-induced activation of ERK-2 by more than 90% but enhanced
IL-1ß-stimulated induction of PDGF-R
expression fourfold. Taken
together, these data suggest that IL-1ß activates both positive and
negative signaling pathways that control the expression of PDGF-R
.
IL-1ß appears to mediate its negative effects on PDGF-R
expression
via MAP kinase activation, while the factor(s) that mediate induction
of PDGF-R
remain to be elucidated.
This article has been cited by other articles:
![]() |
M. R. Bonello and L. M. Khachigian Fibroblast Growth Factor-2 Represses Platelet-derived Growth Factor Receptor-{alpha} (PDGFR-{alpha}) Transcription via ERK1/2-dependent Sp1 Phosphorylation and an Atypical cis-Acting Element in the Proximal PDGFR-{alpha} Promoter J. Biol. Chem., January 23, 2004; 279(4): 2377 - 2382. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gupta, N. H. Purcell, A. Lin, and S. Sen Activation of nuclear factor-{kappa}B is necessary for myotrophin-induced cardiac hypertrophy J. Cell Biol., December 23, 2002; 159(6): 1019 - 1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Hagood, A. Mangalwadi, B. Guo, M. W. MacEwen, L. Salazar, and G. M. Fuller Concordant and Discordant Interleukin-1-Mediated Signaling in Lung Fibroblast Thy-1 Subpopulations Am. J. Respir. Cell Mol. Biol., June 1, 2002; 26(6): 702 - 708. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. SRIVASTAVA, W. N. ROM, J. JAGIRDAR, T.-A. YIE, T. GORDON, and K.-M. TCHOU-WONG Crucial Role of Interleukin-1beta and Nitric Oxide Synthase in Silica-induced Inflammation and Apoptosis in Mice Am. J. Respir. Crit. Care Med., February 15, 2002; 165(4): 527 - 533. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Chan, K. R. Morris, J. T. Belisle, P. Hill, L. K. Remigio, P. J. Brennan, and D. W. H. Riches Induction of Inducible Nitric Oxide Synthase-NO{middle dot} by Lipoarabinomannan of Mycobacterium tuberculosis Is Mediated by MEK1-ERK, MKK7-JNK, and NF-{kappa}B Signaling Pathways Infect. Immun., April 1, 2001; 69(4): 2001 - 2010. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Lindroos, Y.-Z. Wang, A. B. Rice, and J. C. Bonner Regulation of PDGFR-{alpha} in rat pulmonary myofibroblasts by staurosporine Am J Physiol Lung Cell Mol Physiol, February 1, 2001; 280(2): L354 - L362. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hou, S. Moller, L. Edvinsson, and D. Erlinge Cytokines Induce Upregulation of Vascular P2Y2 Receptors and Increased Mitogenic Responses to UTP and ATP Arterioscler. Thromb. Vasc. Biol., September 1, 2000; 20(9): 2064 - 2069. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-Z. Wang and J. C. Bonner Mechanism of Extracellular Signal-Regulated Kinase (ERK)-1 and ERK-2 Activation by Vanadium Pentoxide in Rat Pulmonary Myofibroblasts Am. J. Respir. Cell Mol. Biol., May 1, 2000; 22(5): 590 - 596. [Abstract] [Full Text] |
||||
![]() |
W. Ma, W. Lim, K. Gee, S. Aucoin, D. Nandan, M. Kozlowski, F. Diaz-Mitoma, and A. Kumar The p38 Mitogen-activated Kinase Pathway Regulates the Human Interleukin-10 Promoter via the Activation of Sp1 Transcription Factor in Lipopolysaccharide-stimulated Human Macrophages J. Biol. Chem., April 20, 2001; 276(17): 13664 - 13674. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-Z. Wang, P. Zhang, A. B. Rice, and J. C. Bonner Regulation of Interleukin-1beta -induced Platelet-derived Growth Factor Receptor-alpha Expression in Rat Pulmonary Myofibroblasts by p38 Mitogen-activated Protein Kinase J. Biol. Chem., July 14, 2000; 275(29): 22550 - 22557. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Zhang, Y.-Z. Wang, E. Kagan, and J. C. Bonner Peroxynitrite Targets the Epidermal Growth Factor Receptor, Raf-1, and MEK Independently to Activate MAPK J. Biol. Chem., July 14, 2000; 275(29): 22479 - 22486. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |